Is Ibrance Cytotoxic

Is Ibrance Cytotoxic

Bottom Line. Ibrance is not a traditional form of chemotherapy. It is an oral medication known as a “targeted therapy” and is in the class of drugs known as CDK 4/6 inhibitors. It helps to slow cell growth in both cancer cells and healthy cells.

Is Ibrance a cytotoxic drug?

Bottom Line. Ibrance is not a traditional form of chemotherapy. It is an oral medication known as a “targeted therapy” and is in the class of drugs known as CDK 4/6 inhibitors. It helps to slow cell growth in both cancer cells and healthy cells.

Is Ibrance considered a chemo drug?

IBRANCE® IS THE FIRST FDA-APPROVED MEDICATION in its class. IBRANCE is a targeted therapy known as a CDK 4/6 inhibitor. It is not a traditional chemotherapy. Taken in combination with certain hormonal therapies, IBRANCE works to put the brakes on cell growth in both healthy and cancer cells.

Sarah Jenkins
Author

Sarah Jenkins

Sarah Jenkins is a veteran tech journalist with over 12 years of experience covering artificial intelligence, mobile innovations, and digital ethics. Her insights have appeared in leading technology publications worldwide.